We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Canada Weighs Progressive Licensing to Improve Postmarketing Drug Safety
Canada Weighs Progressive Licensing to Improve Postmarketing Drug Safety
April 12, 2007
A recent discussion paper issued by Health Canada proposes a new system of “progressive” licensing of prescription drugs to improve information on safety and efficacy after they are approved for use.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor